Beverly Moy - Dissemin

Dissemin is shutting down on January 1st, 2025

Language
Login

All papers authored by Beverly Moy

This paper was not found in any repository, but could be made available legally by the author.

2024 Aditya Bardia

ORCID

ORCID

, Nayana Thimmiah

ORCID

, James T. Coates

ORCID

ORCID

, Rachel O. Abelman

ORCID

ORCID

, Beverly Moy

ORCID

ORCID

, Mark N. Melkonyan

ORCID

, Ann Partridge

ORCID

ORCID

, Jeffrey Peppercorn

ORCID

, Heather Parsons

ORCID

, Seth A. Wander

ORCID

and 8 other authors

Antibody–Drug Conjugate Sacituzumab Govitecan Enables a Sequential TOP1/PARP Inhibitor Therapy Strategy in Patients with Breast Cancer

Upload

This paper is made freely available by the publisher.

2023 Beverly Moy

ORCID

, Antonio C. Wolff

ORCID

, R. Bryan Rumble

ORCID

, Kimberly H. Allison, Lisa A. Carey

ORCID

Chemotherapy and Targeted Therapy for Endocrine-Pretreated or Hormone Receptor–Negative Metastatic Breast Cancer and Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A

Download from doi.org

This paper was not found in any repository, but could be made available legally by the author.

2021 Beverly Moy

ORCID

, Mafalda Oliveira, Cristina Saura, William Gradishar, Sung-Bae Kim, Adam Brufsky, Sara A. Hurvitz, Larisa Ryvo, Daniele Fagnani, Sujith Kalmadi, Paula Silverman, Suzette Delaloge, Jesus Alarcon, Ava Kwong, Keun Seok Lee and 10 other authors

Neratinib + capecitabine sustains health-related quality of life in patients with HER2-positive metastatic breast cancer and ≥ 2 prior HER2-directed regimens

Upload

Missing publications? Search for publications with a matching author name.